Zealand Pharma and Generate Biomedicines Partner on AI Protein Drugs
Zealand Pharma and Generate Biomedicines have entered collaboration and license agreement to develop protein therapeutics engineered with AI for metabolic diseases.
AI-designed Protein Drugs | 14/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy